Article
Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2018
Chicard Mathieu, Colmet-Daage Leo, Clement Nathalie, Danzon Adrien, Bohec Mylène, Bernard Virginie, Baulande Sylvain, Bellini Angela, Deveau Paul, Pierron Gaëlle, Lapouble Eve, Janoueix-Lerosey Isabelle, Peuchmaur Michel, Corradini Nadège, Defachelles Anne Sophie, Valteau-Couanet Dominique, Michon Jean, Combaret Valérie, Delattre Olivier, Schleiermacher Gudrun
Abstract excerpt
Purpose: Neuroblastoma displays important clinical and genetic heterogeneity, with emergence of new mutations at tumor progression.Experimental Design: To study clonal evolution during treatment and follow-up, an innovative method based on circulating cell-free DNA (cfDNA) analysis by whole-exome sequencing (WES) paired with target sequencing was realized in sequential liquid biopsy samples of 19 neuroblastoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
